Jim Van Meerten's  Instablog

Jim Van Meerten
Send Message
Jim Van Meerten is an advisor to Marketocracy Capital Management and writes on financial subjects here and on Barchart Portfolio Blogs and Seeking Alpha. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and... More
My company:
Marketocracy capital management
My blog:
Barchart Portfolio Blogs
  • Watson Pharmaceuticals - Barchart Chart of the Day 0 comments
    Jun 29, 2011 7:55 AM | about stocks: AGN

     Barchart.coms Chart of the Day - Watson Pharmaceuticals (WPI)

    Barchart Research Team - Barchart.com - Tue Jun 28, 7:05PM CDT
    Related Stocks
    WPI - Watson Pharmaceuticals
    Sym Last Chg Pct
    WPI 68.20 +2.75 +4.20%

    The "Chart of the Day" is Watson Pharmaceuticals (WPI), which showed up on Tuesday's Barchart "NYSE 12-month high" list. WPI rallied up to a 10-3/4 year high Tuesday of $68.29 and finished the day up +4.2%. WPI now has its sights set on the all-time high of $71.50 posted back in Sep 2000. Trendspotter (tm) has been long WPI for the past 2-1/2 months at a price of $54.81 as WPI has been in a steady uptrend for the past 2-1/2 years. On Tuesday, the U.S. District Court in Delaware ruled in favor of WPI against Endo Pharmaceutical, which is trying to defend the patents on its Lidoderm pain patch. WPI is hoping to market its own generic version of Lidoderm and the court's ruling today could hurt Endo's position as the companies prepare to go to trial in February. Jefferies & Co. analyst Corey Davis said the judge found that the disputed patent covered only one of a group of ingredients, as Watson had argued, while Endo argued the patent covered one or more ingredients. Davis said that if Watson's generic is approved, it will probably not reach the market until mid-2013 at the earliest. Watson Pharmaceuticals, with a market cap of $8.304 billion is a pharmaceutical company primarily engaged in the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company's branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women's Health and General Products. The company's products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.


    How we found the Chart of the Day:

    We found the "Chart of the Day" by scanning the Barchart "New Highs/Lows" page. Then we clicked on the entry for NYSE 12-month highs. A new 12-month high is a popular sign of upside momentum. Then we applied a "Custom View" heading with the Barchart Opinion ranking as one of the columns. we then sorted the list by the Barchart Opinion ranking in order to find the stocks with the highest Opinion.

    Barchart's Opinion trading systems are mostly a Buy and Barchart's daily Trendspotter(tm) trading system is a "Buy." Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

    • Trendspotter: Buy
    • Short-Term Indicators: 100% Buy
    • Medium-Term Indicators: 100% Buy
    • Long-Term Indicators: 100% Buy
    • Overall Average 100% Buy

    Barchart links for further information:

    Quotes and Charts
    Detailed Quote

    Technical Analysis
    Technicals Summary
    Trader's Cheat Sheet™

    Barchart Opinions
    Barchart Opinion
    Barchart Snapshot
    Trading Strategies

    Company Info
    Company Profile
    Key Statistics
    Income Statement-Quarterly
    Income Statement-Annual
    Balance Sheet-Current
    Balance Sheet-Annual

    Chart of the Day Archive
    View Past Chart of the Day Reports
    Stocks: AGN
Back To Jim Van Meerten's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $AVGO - 96% technical buy signals - 11 new highs and up 10.15% in the last month - Relative Strength Index 65.65%
    4 days ago
  • $ULTA - 96% technical buy signals - 11 new highs and up 5.76% in the last month - Relative Strength 69.50%
    4 days ago
  • $XLNX - 100% technical buy signals - 14 new highs and up 11.64% in the last month - Relative Strength Index 79.15%
    4 days ago
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.